ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 79 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $5,898,000 | +22.0% | 349,005 | +18.5% | 0.00% | 0.0% |
Q3 2016 | $4,834,000 | +18.7% | 294,600 | +9.5% | 0.00% | 0.0% |
Q2 2016 | $4,072,000 | +20.5% | 268,987 | +15.1% | 0.00% | 0.0% |
Q1 2016 | $3,378,000 | -34.2% | 233,601 | +28.9% | 0.00% | 0.0% |
Q4 2015 | $5,133,000 | +87.0% | 181,260 | +10.5% | 0.00% | – |
Q3 2015 | $2,745,000 | -11.0% | 163,999 | +39.4% | 0.00% | – |
Q2 2015 | $3,086,000 | +492.3% | 117,687 | +295.3% | 0.00% | – |
Q1 2015 | $521,000 | +24.9% | 29,769 | +24.1% | 0.00% | – |
Q4 2014 | $417,000 | -9.2% | 23,993 | -2.6% | 0.00% | – |
Q3 2014 | $459,000 | -15.9% | 24,644 | -17.5% | 0.00% | – |
Q2 2014 | $546,000 | – | 29,877 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |